You are here

Zynyz

Incyte’s Zynyz Wins FDA Approval as Single and Combo Therapy for Anal Cancer

Xtalks

Thu, 06/5/25 - 11:11 am

Incyte's PD-1 drug brings immunotherapy to anal cancer

Pharmaphorum

Fri, 05/16/25 - 11:16 am

With Jakafi's patent cliff looming, Incyte looks to 2025 launches to bulk up revenue by decade's end

Fierce Pharma

Wed, 10/30/24 - 11:42 am

graft vs host disease

follicular lymphoma

squamous cell anal carcinoma

ESMO: Even after unique trial win, Incyte CEO views PD-1 drug Zynyz as pipeline aide

Fierce Pharma

Sun, 09/15/24 - 06:27 pm

In a surprise approval, FDA green-lights Incyte's PD-1 inhibitor to treat rare cancer type

Fierce Pharma

Wed, 03/22/23 - 09:27 pm

Merkel cell carcinoma